Find trials
Search tips

Dose of Labeled Cholesterol for Kinetics: A Pilot Study

Overview

About this study

This is a pilot study to determine the optimum time and dose to draw blood samples using a tracer for HDL kinetics.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Healthy men and women ages 18 - 50

Exclusion Criteria:

  • Cardiovascular disease
  • Metabolic disease
  • Hematologic disorder
  • Liver or kidney disease
  • phenylketonuria
  • Currently taking lipid lowering medications or any other drugs that could affect lipid metabolism

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Ananda Basu, M.B.B.S., M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20117952

Mayo Clinic Footer